Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Phase 2
150
about 4.4 years
18+
1 site in MA
What this study is about
This trial is testing whether prophylactic levetiracetam (Keppra) reduces seizures in adults with brain metastases located in the primary motor cortex. Participants will be randomly assigned to receive either levetiracetam or standard care, which does not include levetiracetam.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Levetiracetam (Keppra)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
levetiracetam
oral (Oral Tablet)
Secondary: Overall survival, Performance status, Progression free survival, Quality of life/symptom burden and interference
Neurology